Sonoma pharmaceuticals and emc pharma announce collaboration to co-market an expanded eye care product line

Boulder, co / accesswire / september 11, 2024 / sonoma pharmaceuticals, inc. (nasdaq:snoa), a global healthcare leader developing and producing patented microcyn® technology based stabilized hypochlorous acid (hocl) products for a wide range of applications, including wound care, eye, oral and nasal care, dermatological conditions, podiatry, and animal health care, in partnership with emc pharma, llc, today announced they have entered into a co-marketing agreement to launch and sell an expanded prescription and otc eye care product line. the new eye care line will also feature refreshed design and improved packaging for ocucyn® eyelid & eyelash cleanser.
SNOA Ratings Summary
SNOA Quant Ranking